Try
Viatris Inc
VTRSUnited States
51 filed reports · 527 financial concepts · 2 earnings calls · 0 media appearances
Filed reports
51 reports · Dec 2019 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 120 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 20 | 5,098 | Mar 2020 to Jun 2026 |
| Current · 8-KSEC EDGAR | 19 | 87 | Dec 2020 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 7 | 4,202 | Dec 2019 to Dec 2025 |
| Annual · 10-K/ASEC EDGAR | 5 | 13 | Dec 2020 to Dec 2024 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 6, 2026 | 6 | Open |
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 6, 2026 | 595 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | May 7, 2026 | 5 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 7, 2026 | 382 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Feb 26, 2026 | 2 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 26, 2026 | 1,265 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 6, 2025 | 422 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Aug 7, 2025 | 1 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 7, 2025 | 256 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 8, 2025 | 258 | Open |
| FY2024 | 10-K/A | Dec 31, 2024 | Apr 30, 2025 | 1 | Open |
| FY2024 Q4 | 8-K | Dec 31, 2024 | Feb 27, 2025 | 1 | Open |
Financial data
527 concepts · 9,400 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial488 concepts · 7,390 facts · Dec 2016 to Aug 2026
- Cash cash equivalents restricted cash and restricted cash equivalents44 · Dec 2017 to Jun 2026
- Common stock par or stated value per share40 · Dec 2019 to Jun 2026
- Income tax expense benefit39 · Dec 2018 to Jun 2026
- Operating expenses (US GAAP)39 · Dec 2018 to Jun 2026
- Other comprehensive income loss net of tax39 · Dec 2018 to Jun 2026
- Other comprehensive income loss tax39 · Dec 2018 to Jun 2026
- Other nonoperating income expense39 · Dec 2018 to Jun 2026
- Revenue39 · Dec 2018 to Jun 2026
- Stockholders equity including portion attributable to noncontrolling interest38 · Dec 2017 to Jun 2026
- Accumulated other comprehensive income loss net of tax37 · Dec 2019 to Jun 2026
- Cash and cash equivalents at carrying value36 · Dec 2018 to Jun 2026
- Interest expense (US GAAP)36 · Dec 2018 to Jun 2026
- Restricted cash and cash equivalents at carrying value36 · Dec 2018 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect35 · Dec 2018 to Jun 2026
- Net cash provided by used in financing activities35 · Dec 2018 to Jun 2026
- Net cash provided by used in investing activities35 · Dec 2018 to Jun 2026
- Net cash provided by used in operating activities35 · Dec 2018 to Jun 2026
- Share based compensation arrangement by share based payment award options outstanding number35 · Dec 2017 to Jun 2026
- Share based compensation arrangement by share based payment award options outstanding weighted average exercise price35 · Dec 2017 to Jun 2026
- Additional paid in capital34 · Dec 2019 to Jun 2026
- Adjustment for amortization34 · Dec 2018 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value34 · Dec 2018 to Jun 2026
- Amortization of intangible assets34 · Dec 2018 to Jun 2026
- Assets34 · Dec 2019 to Jun 2026
Segment15 concepts · 1,265 facts · Dec 2018 to Jun 2026
- Revenue520 · Dec 2018 to Jun 2026
- Goodwill125 · Dec 2019 to Jun 2026
- Operating income loss120 · Dec 2018 to Jun 2026
- Goodwill translation and purchase accounting adjustments116 · Dec 2019 to Jun 2026
- Restructuring charges79 · Dec 2019 to Jun 2026
- Operating Segments56 · Dec 2022 to Jun 2026
- Revenue not from contract with customer48 · Dec 2022 to Jun 2026
- Goodwill impairment loss47 · Dec 2022 to Dec 2025
- Goodwill acquired during period44 · Dec 2019 to Dec 2024
- Operating Segment32 · Mar 2024 to Jun 2026
- Goodwill transfers28 · Mar 2022 to Dec 2023
- Upjohn Inc.24 · Dec 2020 to Dec 2021
- Revenue from contracts with customers (excluding tax)10 · Dec 2022 to Dec 2025
- Revenue (excluding assessed tax)9 · Mar 2021 to Dec 2025
- Greater China7 · Mar 2025 to Dec 2025
Product2 concepts · 515 facts · Dec 2018 to Jun 2026
- Revenue496 · Dec 2018 to Jun 2026
- Revenue not from contract with customer19 · Dec 2019 to Jun 2024
Geography11 concepts · 120 facts · Dec 2018 to Dec 2025
- Effective income tax rate reconciliation tax credits foreign31 · Dec 2018 to Dec 2021
- Revenue21 · Dec 2018 to Dec 2025
- Effective income tax rate reconciliation change in deferred tax assets valuation allowance11 · Dec 2018 to Dec 2024
- Effective income tax rate reconciliation other adjustments11 · Dec 2018 to Dec 2024
- Effective income tax rate reconciliation foreign income tax rate differential7 · Dec 2018 to Dec 2024
- Effective income tax rate reconciliation tax contingencies7 · Dec 2018 to Dec 2024
- Effective income tax rate reconciliation tax credits7 · Dec 2018 to Dec 2024
- Effective income tax rate reconciliation tax credits research7 · Dec 2018 to Dec 2024
- Effective income tax rate reconciliation tax settlements7 · Dec 2018 to Dec 2024
- Other Foreign Operations7 · Dec 2018 to Dec 2024
- Effective income tax rate reconciliation change in enacted tax rate4 · Dec 2018 to Dec 2021
Guidance11 concepts · 110 facts · Feb 2021 to Aug 2026
- Revenue Guidance40 · Feb 2021 to Aug 2026
- Free Cash Flow Guidance34 · May 2021 to Aug 2026
- EPS (Diluted) Guidance16 · Feb 2024 to Aug 2026
- Gross Margin Guidance4 · Feb 2021 to Nov 2023
- Revenue Growth Guidance4 · Aug 2024 to Nov 2024
- Capital Expenditures Guidance2 · Feb 2021
- Effective Tax Rate Guidance2 · Feb 2021
- Effective Tax Rate Guidance (Adjusted (non-GAAP))2 · Feb 2021
- Free Cash Flow Guidance (Adjusted (non-GAAP))2 · Feb 2021
- Gross Margin Guidance (Adjusted (non-GAAP))2 · Feb 2021
- Net Income Guidance2 · Feb 2021
Segments
1,900 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments15 members · 1,265 facts
- Greater China282 · Dec 2018 to Jun 2026
- Developed Markets280 · Dec 2018 to Jun 2026
- Emerging Markets275 · Dec 2018 to Jun 2026
- Japan Australia And New Zealand275 · Dec 2018 to Jun 2026
- Greater china segment39 · Dec 2019 to Jun 2026
- Emerging markets segment32 · Dec 2019 to Jun 2026
- Developed markets segment30 · Dec 2019 to Jun 2026
- Japan australia and new zealand segment28 · Dec 2019 to Mar 2025
- Corporate And Other5 · Mar 2022 to Jun 2026
- Europe5 · Mar 2025 to Dec 2025
- North America5 · Mar 2025 to Dec 2025
- North america segment3 · Apr 2021 to Dec 2022
- Japan Austalia And New Zealand2 · Jun 2024 to Sep 2024
- Other2 · Jun 2023 to Sep 2023
- Europe segment2 · Apr 2021
Product or service20 members · 515 facts
- Brands34 · Dec 2018 to Jun 2026
- Generics34 · Dec 2018 to Jun 2026
- Product And Service Other29 · Dec 2018 to Jun 2024
- Amitiza27 · Mar 2021 to Jun 2026
- Celebrex27 · Mar 2021 to Jun 2026
- Creon27 · Mar 2021 to Jun 2026
- Dymista27 · Mar 2021 to Jun 2026
- Effexor27 · Mar 2021 to Jun 2026
- Epi Pen Auto Injectors27 · Mar 2021 to Jun 2026
- Lipitor27 · Mar 2021 to Jun 2026
- Lyrica27 · Mar 2021 to Jun 2026
- Norvasc27 · Mar 2021 to Jun 2026
- Viagra27 · Mar 2021 to Jun 2026
- Xalabrands27 · Mar 2021 to Jun 2026
- Xanax27 · Mar 2021 to Jun 2026
- Yupelri27 · Mar 2021 to Jun 2026
- Zoloft27 · Mar 2021 to Jun 2026
- Complex GX And Biosimilars20 · Dec 2018 to Sep 2023
- Influvac15 · Sep 2021 to Dec 2025
- Product5 · Dec 2019 to Dec 2023
Statement geographical12 members · 120 facts
- US51 · Dec 2018 to Dec 2025
- Non Us25 · Dec 2018 to Dec 2024
- CN7 · Dec 2019 to Dec 2025
- FR7 · Dec 2018 to Dec 2021
- CH4 · Dec 2018 to Dec 2021
- GI4 · Dec 2018 to Dec 2021
- IE4 · Dec 2018 to Dec 2021
- LU4 · Dec 2018 to Dec 2021
- Otherforeign4 · Dec 2018 to Dec 2021
- PR4 · Dec 2018 to Dec 2021
- IN3 · Dec 2018 to Dec 2020
- SG3 · Dec 2019 to Dec 2021
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary98 claims from 8 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary154 claims from 8 reports · Dec 2024 to Jun 2026
- Risk-factor changes9 claims from 1 reports · Dec 2025
- Risk factors89 risks from 2 annual reports · 2024 to 2025
Earnings calls
2 calls · May 2026 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 6, 2026
- FY2026 Q1May 7, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.